Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-05
1997-01-28
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514252, 514267, 544145, 544163, 544234, 544249, 544250, 544251, 544278, 544350, 544409, 546114, 546115, 546118, 546286, 548427, 549 57, 549236, A61K 31505, C07D49504, C07D49514, C07D48704
Patent
active
055978231
ABSTRACT:
The present invention relates to a compound of the formula ##STR1## and the pharmaceutically acceptable salts thereof wherein W is a tricyclic heterocyclic ring system; which is an .alpha.-1 adrenergic antagonist and is useful in the treatment of BPH; also disclosed are .alpha.-1 antagonist compositions and a method for antagonizing .alpha.-1 receptors and treating BPH.
REFERENCES:
patent: 5049564 (1991-09-01), DeBernardis et al.
Altenbach Robert J.
Basha Fatima Z.
Carroll William A.
Drizin Irene
Elmore Steven W.
Abbott Laboratories
Bernhardt Emily
Janssen Jerry F.
Steele Gregory W.
LandOfFree
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrener does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrener, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrener will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-941651